文献速递淋巴瘤

外周T细胞淋巴瘤非特指型

Peripheral T-cell lymphoma, not otherwise specified.
PubMed 文献 · Blood · 2017-01-23

外周T细胞淋巴瘤非特指型(PTCL-NOS)是生物学和临床异质性大、无法归入WHO其他定义实体的疾病类别。含蒽环类方案CHOP为当前标准一线治疗;获满意缓解者可考虑自体干细胞移植巩固以提高长期生存机会。部分患者原发耐药或缓解后早期复发且适合移植者少,普拉曲沙、罗米地辛、贝利司他和维布妥昔单抗已基于活性获批用于复发/难治PTCL,但未显著改善生存率。将新药纳入CHOP骨架的研究正在进行,以期提高缓解率、使更多患者缓解后接受移植并延长生存。

要点

  • CHOP为PTCL-NOS标准一线治疗,满意缓解者可考虑自体干细胞移植巩固。
  • 普拉曲沙、罗米地辛、贝利司他和维布妥昔单抗已获批用于复发/难治PTCL。
  • 上述新药基于活性获批,但未显著影响生存率。

核心结论

  • CHOP仍是PTCL-NOS标准一线治疗,满意缓解者可行自体干细胞移植巩固以争取长期生存。
  • 普拉曲沙、罗米地辛、贝利司他和维布妥昔单抗已基于活性获批用于复发/难治PTCL,但未显著影响生存率。
  • 将新药纳入CHOP骨架的研究正在进行,旨在提高缓解率、使更多患者缓解后接受移植并延长生存。

研究设计与样本

  • 本文为综述,检索范围原文未报告。

主要发现

  • 部分PTCL-NOS患者治疗耐药或缓解后不久复发,仅少数适合移植。
  • 普拉曲沙、罗米地辛、贝利司他和维布妥昔单抗已获批用于复发/难治PTCL,但未显著影响生存率。

临床怎么用

  • 含蒽环类方案CHOP为当前标准一线治疗。
  • 获满意缓解者可考虑自体干细胞移植巩固以提高长期生存机会。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Peripheral T-cell lymphoma, not otherwise specified, is a broad category of biologically and clinically heterogeneous diseases that cannot be further classified into any other of the existing entities defined by the World Health Organization classification. Anthracycline-containing regimens, namely cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP), nowadays represent the standard first-line treatment; for patients who achieve a satisfactory response, a consolidation by means of autologous stem cell transplantation may offer a greater chance of long-term survival. Several patients, however, display treatment refractoriness or relapse soon after obtaining a response, and just a few of them are suitable transplant candidates. This is why several new agents, with innovative mechanisms of action, have been investigated in this context: pralatrexate, romidepsin, belinostat, and brentuximab vedotin have been approved for relapsed and refractory peripheral T-cell lymphomas based on their activity, although they do not significantly affect survival rates. The incorporation of such new drugs within a CHOP backbone is under investigation to enhance response rates, allow a higher proportion of patients to be transplanted in remission, and prolong survival.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Broccoli A, Zinzani PL. Peripheral T-cell lymphoma, not otherwise specified. Blood. 2017. PMID: 28115372. doi:10.1182/blood-2016-08-692566

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。